1.Poorly controlled gout: who is doing poorly?
Singapore medical journal 2016;57(8):412-414
Gout, an inflammatory arthritis caused by the deposition of monosodium urate crystals, is commonly seen in primary care and specialist clinics. In recent years, there has been a resurgence of interest in gout due to advances in therapies and the understanding of pathophysiology, with new guidelines being published by international bodies. However, there is still a gap between the goals of treatment and actual day-to-day practice. Barriers that result in poorly controlled gout include patient factors such as lack of understanding of the disease, stigma and nonadherence to treatment, as well as physician factors such as knowledge gaps, inadequate use of allopurinol and lack of ownership of the disease. The medical profession needs to do more to bridge the gap through physician and patient education, identification of treatment targets with appropriate use of drugs, and dissemination of guidelines.
Allopurinol
;
therapeutic use
;
Arthritis
;
therapy
;
Comorbidity
;
Gout
;
drug therapy
;
Humans
;
Hyperuricemia
;
drug therapy
;
Inflammation
;
Medication Adherence
;
Patient Education as Topic
;
Primary Health Care
;
Professional-Patient Relations
;
Rheumatology
;
methods
;
Singapore
;
Uric Acid
;
therapeutic use
2.Love in the time of coronavirus: training and service during COVID-19.
Chen Seong WONG ; Woo Chiao TAY ; Xing Fu HAP ; Faith Li-Ann CHIA
Singapore medical journal 2020;61(7):384-386
Betacoronavirus
;
Coronavirus Infections
;
epidemiology
;
transmission
;
Disease Transmission, Infectious
;
prevention & control
;
Education, Medical, Graduate
;
organization & administration
;
Humans
;
Internship and Residency
;
organization & administration
;
Pandemics
;
Pneumonia, Viral
;
epidemiology
;
transmission
;
Quality Improvement
3.A retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergy
Bernard Yu Hor THONG ; Faith Li Ann CHIA ; Sze Chin TAN ; Teck Choon TAN ; Khai Pang LEONG ; Justina Wei Lyn TAN ; Chwee Ying TANG ; Jin Feng HOU ; Grace Yin Lai CHAN ; Hiok Hee CHNG
Asia Pacific Allergy 2014;4(3):156-163
BACKGROUND: Antituberculosis (anti-TB) drug allergy often involves multiple concurrently administered drugs which subsequently need to be reinitiated as no better alternatives exist. OBJECTIVE: To describe the results of tailored sequential desensitization-rechallenge (D-R) for anti-TB drug allergy. METHODS: Consecutive patients who had undergone D-R to anti-TB drugs between 1 September 1997 and 31 January 2012 were recruited. Following resolution of the acute reaction, anti-TB drug was restarted at 1:6,000 to 1:3 of the final daily dose (FDD), with gradual single or multiple step daily dose escalation to the FDD. Subsequent drugs were sequentially added ≥3 days later when the preceding drug was tolerated. Full blood count and liver function tests were monitored prior to addition of each new drug. RESULTS: There were 11 patients of whom 10 were male, predominantly Chinese (8 patients). Regimens comprised at least 3 drugs: isoniazid (INH), rifampicin (RIF), ethambutol (EMB), pyrazinamide (PZA), or streptomycin. All patients had nonimmediate reactions, with cutaneous eruptions, where maculopapular exanthema (MPE) was the most common (8 patients). Drug-induced hypersensitivity syndrome (DIHS) occurred in 6 patients, and Stevens Johnson syndrome (SJS) in 2 patients. D-R to INH was successful in 7/9 patients (77.8%) and to RIF/EMB/PZA/streptomycin in all. Of the 2 patients who failed INH D-R, 1 developed fever and MPE on day 3, the other MPE on day 8. D-R with INH and RIF respectively was successful in 2 patients with SJS. Among DIHS patients, 1 failed D-R with INH (fever and MPE on day 3). There were 23/25 (92%) successful D-R among the 11 patients. All patients completed TB treatment of ≥5 months' duration with no cases of drug-resistant TB. CONCLUSION: Tailored sequential TB drug D-R is successful where no better alternative therapies are available, with careful dose escalation and close monitoring, and after a careful risk-benefit assessment.
Asian Continental Ancestry Group
;
Complementary Therapies
;
Drug Eruptions
;
Drug Hypersensitivity Syndrome
;
Drug Hypersensitivity
;
Ethambutol
;
Exanthema
;
Fever
;
Humans
;
Hypersensitivity
;
Isoniazid
;
Liver Function Tests
;
Male
;
Pyrazinamide
;
Retrospective Studies
;
Rifampin
;
Risk Assessment
;
Stevens-Johnson Syndrome
;
Streptomycin